We identified another tcsABCD genes encoding biosynthesis of the allylmalonyl-CoA in new FK506 producing strain, Streptomyces sp. KCCM 11116P. The functionality of tcsABCD is confirmed by gene deletion. To validate the functionality of these genes, tcsABCD genes were heterologously expressed in Streptomyces hygroscopicus ATCC 14891 using pSE34. The resulting strain produced the FK506 which showed a molecular ion [M?NH 4 ] ? at m/z 821 as verified by LC/ESI-MS. To address the function of TcsB in the allylmalonyl-CoA pathway, we pursued the construction of two different combinations: the heterologous FabH-like b-ketoacyl-acyl carrier protein synthase III gene expression and chemical complementation. Plasmidbased expression of the fabH homolog dpsC in DTcsB using pSE34 and pSET152(ermE*) led to restoration of approximately 32.2 and 28.7 % of the levels of FK506 relative to Streptomyces sp. KCCM 11116P, respectively. Furthermore, the addition of propionic acid to the culture of DTcsB restored FK506 production up to 35.6 % of overall FK506 levels in Streptomyces sp. KCCM 11116P. We have engineered production of 36-methyl-FK506 in DTcsB. The heterologous expression of Syteptomyces glaucescens FabH in DTcsB gave rise to 5.9-fold increase in the 36-methyl-FK506 level as compared with mutasynthetic production by 4-methylpentanoic acid. Supplementing the culture broth of DTcsB expressing S. glaucescens FabH with valine resulted in an additional 2.5-fold increase in the 36-methyl-FK506 titer. Overall, this study shows that TcsB was found to maintain a very high-specific activity for propionyl-CoA in allylmalonyl-CoA biosynthetic work and S. glaucescens FabH which use isobutyryl-CoA as substrate can initiate methyl side chain biosynthesis in 36-methyl-FK506 in DTcsB.
Introduction
Members of the genus Streptomyces are well-known as fairly good producer of pharmaceutically relevant natural products with wide-ranging biological activities that including antimicrobial, anticancer, and immunosuppressant activities. FK506, also called tacrolimus, is an important immunosuppressive macrocyclic polyketide discovered in the soil bacterium Streptomyces tsukubaensis in 1987 (Kino et al. 1987a, b) . The immunosuppressive mechanism of FK506 is related to the binding of an immunophilin, FKBP12 (Aldape et al. 1992) , and the FK506/FKBP12 complex then bind to a Ca 2? -regulated serine/threonine phosphatase, calcineurin, and inhibits its enzymatic activity. By blocking calcineurin, FK506 inhibits phosphatase-controlled translocation of nuclear factor of activated T-cells into the nucleus and thereby prevents induction of genes encoding cytokines and their receptors Electronic supplementary material The online version of this article (doi:10.1007/s13765-015-0139-2) contains supplementary material, which is available to authorized users.
that are required for activation and proliferation of lymphocytes and other immune cells (Schreiber and Crabtree 1992) . Nowadays, it is used following bone marrow, kidney, and liver transplants (Trede et al. 1997; Dumont 2000; Meier-Kriesche et al. 2006) , as well as, for the treatment of inflammatory skin diseases and eczema (Remitz and Reitamo 2009; Lin 2010; Rath 2013) . Moreover, it is gaining additional attention for its potential in treating cancer (Periyasamy et al. 2007 ) and neurological conditions (Kletner and Herdegen 2003) . Owing to the pharmaceutical potential and broad clinical applications described above, considerable time and effort has been expended to increase the yield of FK506 from their own strain, and to develop more efficient and economical processes for industrial production (Kumar et al. 2007; Mo et al. 2013) .
The biological properties of polyketide-derived bioactive natural products are attributed to their specialized chemical structures, which are derived from the condensation of various polyketide synthase (PKS)-extender units Liu et al. 2009; Quade et al. 2011 ).
FK506 and its structural homolog FK520 are synthesized by combined PKS and nonribosomal peptide synthetase systems. The unique structural difference between FK506 and FK520 is derived from the side chain, in which the allyl side chain on carbon 21 of FK506 is replaced by an ethyl side chain in FK520 (Fig. 1) . The allylmalonylcoenzyme A (AM-CoA) biosynthetic pathway has recently been almost elucidated, and it is mediated by four tcs genes (tcsA, tcsB, tcsC, and tcsD), which is unique to the FK506 biosynthetic gene cluster. The ketoacylsynthase TcsB, the propionyl-acylated, catalyzes the condensation of the propyl moiety with malonate loaded on TcsA, which comprises an acyltransferase and an acyl carrier protein (ACP) domain. The resulting b-ketopentyl-ACP TcsA gives rise to the trans-2-pentenyl-ACP TcsA through the action of endogenous fatty acid synthase (FAS) system. polyketide chain as AM-CoA to obtain the allyl side chain on C-21 of FK506 (Mo et al. 2011) . However, the catalytic functions of both b-ketoacyl synthase (KS) domain in TcsB need a more research because they have been not known for their detailed function.
According to analyst reports, annual sales of Prograf, the commercial product derived from FK506 in 2011, reached approximately $ 2 billion, representing 27.6 % of the annual sales in the immunosuppressant market (Martínez-Castro et al. 2013) . For this reason, since the first isolation of FK506 from the soil bacterium S. tsukubaensis in 1987 (Kino et al. 1987a, b) , 18 FK506 producer Streptomyces species have been reported until now. We also reported the isolation of new FK506 producing strain, Streptomyces sp. KCCM 11116P, from soil in our previous study (Mo et al. 2013 ), In addition, various modifications of the chemical structure of FK506 have been attempted due to the wide range of pharmacological application and biological activity of FK506. 36-fluoro-and 36-methyl-FK506 have been engineered successfully in the previous through mutasynthetic approach by supplementation of branched carboxylic acid substrates (Mo et al. 2011) . Recently, Moore and colleague reported that 36-methyl-FK506 was enhanced by genetic engineering without chemical complementation (Lechner et al. 2013 ). However, since there are to limit the amount of production, there are required the various approach.
In the present study, we report the identification of another AM-CoA biosynthetic genes, tcsABCD, located on FK506 biosynthetic cluster in new FK506 producing strain, Streptomyces sp. KCCM 11116P. In particular, it was revealed that in-frame gene deletion, cross-complementation with heterologous gene encoding for b-ketoacyl-acyl carrier protein synthase III (KSIII), chemical complementation was able to predict catalytic activity and acyl group specificity for initiating the AM-CoA biosynthetic processes. Furthermore, we have provided the engineered biosynthesis of 36-methyl-FK506 by replaced of the TcsB function with a Streptomyces FAS FabH.
Materials and methods
Bacterial strains, plasmids, and culture conditions All bacterial strains and plasmids used in this study are listed in Supplementary Table 1. Spore generation and seed culture of strains for FK506 production were described previously (Mo et al. 2013) . The spore suspensions were kept in a deep freezer (-80°C) until used for experiments. For measurement of the FK506 production of the Streptomyces sp. KCCM 11116P and its mutant strains, 50 mg of mycelium from the seed culture was inoculated into a baffled 250 mL flask containing 50 mL of R2YE medium at pH 7.2 and cultivated for 6 days at 28°C and 180 rpm. Streptomyces hygroscopicus var. ascomyceticus ATCC 14891 and its derivatives (ATCC 14891/pSE34, ATCC 14891/pSKO) were plated for spore harvesting on ISP3 medium at 28°C. Seed cultures were then prepared in 250-mL-baffled flasks containing 50 mL of Tryptone Soya Broth (Difco, USA) supplemented with 1 % (w/v) glucose, 100 mM MES buffer, and pH 6.0 at 250 rpm for 2 days. Subsequently, 1 % (v/v) of the above seed cultures was used for the inoculation of SY production medium, and the main culture was incubated for 6 days at 28°C at 180 rpm (Wu et al. 2000) . Streptomyces peucetius ATCC 29050 was cultivated in APM medium for genomic DNA isolation (Lomovskaya et al. 1999) . Luria-Bertani, SOB, and SOC liquid media were used to grow the Escherichia coli (Sambrook and Russell 2001) . Apramycin (50 lg/mL), ampicillin (50 lg/mL), kanamycin (50 lg/mL), thiostrepton (25 lg/mL), chloramphenicol (50 lg/mL), and nalidixic acid (25 lg/mL), all obtained from Sigma-Aldrich (USA), were added to the agar media as required.
Construction of in-frame gene deletion plasmid and gene deletion
The standard methods of extraction, cloning, and manipulation of DNA were used for Escherichia coli and Streptomyces spp. (Kieser et al. 2000; Sambrook and Russell 2001) . All primers used in this study are listed in Supplementary Table 2 . The E. coli-Streptomyces shuttle vector pKC1139 was used for gene disruption. To construct plasmids for the disruption of the another AM-CoA biosynthetic genes, tcsA, tcsB, tcsC, and tcsD, the left-and right-flanking fragments of each gene were amplified from genomic DNA derived from the Streptomyces sp. KCCM 11116P strain by polymerase chain reaction (PCR). The primer pairs for PCR the amplification of left-and rightflanking fragments of the target genes (DtcsALF/DtcsALR, DtcsARF/DtcsARR, DtcsBLF/DtcsBLR, DtcsBRF/Dtcs BRR, DtcsCLF/DtcsCLR, DtcsCRF/DtcsCRR, DtcsDLF/ DtcsDLR, and DtcsDRF/DtcsDRR) were designed to amplify a DNA fragment of approximately 1 kb. A total of 8 PCR fragments were separately cloned into the pGEM-T Easy Vector (Promega, USA), then sequenced. After digestion with appropriate restriction enzymes, the 8 fragments obtained were ligated together into the HindIII and EcoRI site of pKC1139 via a three-way ligation to construct 4 different in-frame deletion plasmids: pSKA, pSKB, pSKC, and pSKD. E. coli-Streptomyces conjugation and in-frame deletion experiments were performed using the standard protocol (Kieser et al. 2000) . Finally, each mutant (DTcsA, DTcsB, DTcsC, and DTcsD) was verified by PCR analysis.
Analysis of FK506 derivatives and their analogs from DTcsA, DTcsB, DTcsC, and DTcsD
The FK506-related biosynthetic intermediates and their analogs, which were generated by FK506 producing Streptomyces sp. KCCM 11116P, and its deletion mutants, were extracted with ethyl acetate from the fermentation R2YE broth, and then analyzed by HPLC-ESI-MS/MS as previously described ). Samples were separated on an ACQUITY UPLC BEH C18 column (50 9 2.1 mm, 1.7 lm; Waters, USA) interfaced with a Waters/Micromass Quattro micro/MS instrument tracing by MS/MS using a gradient of acetonitrile at a flow rate of 0.2 mL/min over 50 min starting with 40 % (v/v) aqueous acetonitrile containing 10 mM ammonium acetate and 0.1 % (v/v) acetic acid. Tracing was done by MS/MS operated in multiple reactions monitoring (MRM) mode choosing mass pairs specific for the selected analytes to detect the transition from parent ion as an ammonium adduct to product ion: 821 [ 576 for FK506; 809 [ 564 for FK520; 795 [ 550 for FK523; 823 [ 578 for 36,37-dihydro-FK506 ). Three separate cultivations and independent extractions were performed.
Construction of expression vector pSKO, pDPSC34, pDPSC152, and pSW7
For heterologous expression of another AM-CoA biosynthetic genes in S. hygroscopicus ATCC 14891, the heterologous expression plasmids were constructed by PCR amplification of the fragments of another tcsABCD genes from the genomic DNA derived from the Streptomyces sp. KCCM 11116P (GenBank accession no. HQ696504.1). The primer pair EXtcsABCDL/EXtcsABCDR was designed to PCR amplify the DNA fragments containing the tcsABCD genes (Supplementary Table 2) , and the primer pair for the PCR amplification of another tcsABCD genes was designed to contain the natural ribosomal binding sites of the tcsABCD genes. PCR fragments (6.2 kb for tcsABCD genes) were cloned using the pGEM-T Easy Vector then sequenced. After digestion with the FbaI and XbaI restriction enzymes, the fragments were cloned into the BamHI and XbaI sites of pSE34, yielding pSKO, (Supplementary Table 1) .
Complementation experiments with plasmids expressing two different KSIII enzymes were carried out. The plasmids pDPSC34 and pDPSC152 expressing the S. peucetius dpsC from P ermE* were amplified using primers DpsCF and DpsCR from genomic DNA of S. peucetius (Table 2 in the supplemental material). The use of these primers introduced a BamHI site at the 5 0 end and XbaI restriction sites at the 3 0 end of the dpsC PCR product. The PCR product was cloned using the pGEM-T Easy Vector then sequenced. After digestion with BamHI and XbaI, the fragments were cloned into the BamHI and XbaI sites of the pSE34 and pSET152 (P ermE* ), yielding pDPSC34 and pDPSC152, respectively.
The plasmid pSW7 expressing the Streptomyces glaucescens fabH from P ermE* has been described previously and was generated by inserting the corresponding fabH gene as a BglII fragment into the Streptomyces expression plasmid pSE34 (Mo et al. 2005) . The pDPSC34 and pSW7 were introduced into DTcsB by PEG-mediated protoplast transformation following standard methods (Kieser et al. 2000) , and thiostrepton-resistant transformants were selected in the presence of thiostrepton (25 lg/mL) using standard protocol (Kieser et al. 2000) . The pDPSC152 was introduced into DTcsB by conjugation from E. coli ET12567/pUZ8002, and the exoconjugants were selected in the presence of apramycin (50 lg/mL) using the standard protocol (Kieser et al. 2000) .
Analysis of FK506 production
The level of FK506 production was determined by highperformance liquid chromatography (HPLC). Fifty-milliliter samples of culture broth were extracted twice with an equal volume of ethyl acetate. The organic extract was dried using a rotary evaporator under reduced pressure, then dissolved in 0.2 mL of methanol for use in HPLC analysis. Samples were loaded onto a Supelco Discovery HS C18 column (USA), which was maintained at 50°C. The mobile phase used for isocratic elution was composed of water and acetonitrile (45:55, v/v). The flow rate was 1 mL/min, and detection was carried out at 205 nm. The HPLC analysis method used for the determination of FK506 production was modified from the previously reported methods ). Authentic FK506 (Sigma-Aldrich, USA) were used to create a calibration curve for determination of FK506 yield. The level of FK506 production reported herein represents the average of two series of separate duplicate cultivations and extractions.
Chemical complementation and valine feeding study
Seed cultures of DTcsB were grown in R2YE medium for 3 days at 28°C, then used as a 1 % (v/v) inoculum for a 50 mL liquid culture of the same medium as described above for FK506 production. Propionic acid and acrylic acid (Sigma-Aldrich, USA) were added to a final concentration of 5 mM both at 48 and 72 h. The production cultures were grown for 6 days at 28°C, as described above. The culture broth was then collected by vacuum filtration and extracted twice with an equal volume of ethyl acetate. The organic extract was evaporated to dryness under reduced pressure and then dissolved in 0.2 mL methanol for LC/ESI-MS analysis as previously described ).
Seed culture of the DTcsB/pSW7 was grown in R2YE medium-containing thiostrepton (25 lg/mL) for 3 days at 28°C and then used as a 1 % (v/v) inoculum for 50 mL liquid culture of the same medium. L-valine (SigmaAldrich, USA) was added to a final concentration of 20 mM at 48 h. The production cultures were grown for 6 days at 28°C. The culture broth was then collected and extracted to measure FK506 production as described above. The organic extract was evaporated to dryness under reduced pressure and then dissolved in 0.2 mL methanol for HPLC analysis ). The level of FK506 production reported represents the average of two series of separate duplicate cultivations and extractions. Independent experiments were carried out in triplicate.
Results
Analysis of another AM-CoA biosynthetic genes from new FK506 producing strain, Streptomyces sp.
KCCM 11116P
A total of 100-kb of the new FK506 biosynthetic gene cluster and its flanking regions were clone and sequenced from the FK506 producer strain, Streptomyces sp. KCCM 11116P, and sequences were submitted to the GeneBank database (GeneBank Accession number: HQ696504.1) (Lee et al. 2014) . The homologous genes (GenBank ID ADX99508.1; ADX99509.1; ADX99510.1; and ADX99511.1) of the putative AM-CoA biosynthetic genes from Streptomyces sp. KCTC 11604BP was also sequenced in new FK506 producing strain, Streptomyces sp. KCCM 11116P, which has the FK506 biosynthetic gene cluster that shows 98 % identity to that of Streptomyces sp. KCTC 11604BP (Lee et al. 2014) . To obtain experimental evidence for the functions of tcsA, tcsB, tcsC, and tcsD in FK506 biosynthesis, each gene in Streptomyces sp. KCCM 11116P was inactivated by in-frame deletion to avoid any polar effect (the Supplementary Table 1 ). The deletions of tcsA (DTcsA), tcsB (DTcsB), tcsC (DTcsC), and tcsD (DTcsD) led to the selective loss of FK506 production but not FK520, confirming the dedicated involvement of tcsA, tcsB, tcsC, and tcsD in the biosynthesis of FK506. We also observed that the production of FK523 (35-desmethyl-FK520) from DTcsA, DTcsB, and DTcsC and the production of 36,37-dihydro-FK506 from DTcsD, which can be detected by HPLC-ESI-MS/MS using MRM mode analysis (Fig. 2) ). Based on this result, we prove that these tcsABCD genes in new FK506 producer strain, Streptomyces sp. KCCM 11116P, are essential genes for generating the C21 allyl moiety of FK506. In addition, this result showed that FK523 and 36,37-dihydro-FK506 increased as a result of the misincorporation of methylmalonyl-CoA and propylmalonyl-CoA in the absence of AM-CoA extender unit.
Heterologous expression of another AM-CoA biosynthetic genes in the FK520 producer strain, S. hygroscopicus ATCC 14891
In order to confirm the AM-CoA biosynthesis by tcsABCD genes, we investigated the effect of the aforementioned AM-CoA biosynthetic pathway to affect FK506 production by heterologous expression of the tcsABCD genes in the S. hygroscopicus ATCC 14891 strain. tcsABCD genes of Streptomyces sp. KCCM 11116P were cloned into Streptomyces expression vector pSE34 (Smirnova and Reynolds 2001) , which is an E. coli-Streptomyces shuttle vector containing an ermE* promoter and a thiostrepton resistance marker. This construct (pSKO) was then introduced into the S. hygroscopicus ATCC 14891 strain, and the transformants were confirmed to produce only FK506, as verified by LC/ESI-MS, while no FK506 was detected in the S. hygroscopicus ATCC 14891 strain harboring empty control plasmids (Fig. 3) . The metabolite eluted at 27.2 min showed a molecular ion [M?NH 4 ] ? at m/z 821, which can be interpreted as FK506 (Fig. 3) . The FK506 generated from Streptomyces sp. KCCM 11116P showed an identical LC/ESI-MS chromatogram, which has a molecular ion [M?NH 4 ] ? at m/z 821 (Fig. 3) .
Identification of tcsB as encoding for KS domains by expression of heterologous KSIII gene and chemical complementation
To obtain experimental evidence for the initiation process by TcsB, we examined the effects of plasmid complementation in DTcsB using the expression of the heterologous FabH like-KSIII gene as a dpsC. The DpsC has been shown to function as a FabH like-KSIII, condensing the unique propionyl-CoA, as starter unit, with malonyl-ACP (Bao et al. 1999a, b) . It is very similar to the FabH like-KSIII enzyme, TcsB, of AM-CoA biosynthesis. The plasmid complementation experiment was carried out with dpsC under the control of the constitutive ermE* promoter together with a Streptomyces RBS in DTcsB. In order to prevent unexpected effects caused by the presence of replication mode or copy number present in the plasmid, the constructs pDPSC34 and pDPSC152 were prepared based on the expression plasmid and integrative expression plasmid, pSE34 and pSET152(P ermE* ), for overexpression, respectively. HPLC analyses of Streptomyces sp. KCCM 11116P and DTcsB were carried out using absorbance (205 nm) as detection method. In all case, the FK506 product eluted at 42 min (Fig. 4) . FK506 productions of DTcsB/pDPSC34 and DTcsB/pDPSC152 were only partially restored, reaching 32.2 and 28.7 % of the production observed in the Streptomyces sp. KCCM 11116P, respectively (Table 1 ). This result observed that the restored FK506 production by cross-complementation-based plasmid-base expression of FabH-like KSIII enzyme, DpsC. DpsC-catalyzed elongation of the AM-CoA extension unit using to malonated TcsA is proposed to give rise to recovery of FK506 production. A lower catalytic efficiency with this TcsA substrate than corresponding DpsG or low levels of the KSIII DpsC at this stage of the fermentation would contribute to the observed decreased level of the process. Nonetheless, an apparent production in the level of FK506 in the DTcsB/pDPSC34 and DTcsB/pDPSC152 may indicate that the DpsC with propionyl-CoA as substrate initiates the biosynthetic process of AM-CoA. To obtain further experimental evidence for the function of TcsB in AM-CoA biosynthesis, a putative priming unit of AM-CoA was administered to the tcsB defective mutants, and FK506 production was analyzed. In accordance with the pathway proposed in Fig. 1 , propionic acid was fed into the culture broth of DTcsB in order to restore the FK506 production via condensation with malonate loaded on TcsA. Consequently, supplementation with 10 mM of propionic acid in DTcsB resulted in successful recovery of approximately 35.6 % of overall FK506 levels in Streptomyces sp. KCCM 11116P (Table 1) , which was confirmed by LC/ESI-MS (Fig. 5A ). In addition, mass spectral analysis revealed parent ions [M?NH 4 ] ? with m/z values of 821 for the peak eluting at 21.2 min (Fig. 5B) . This mass is identical with the mass of the FK506 parent ion, also confirming the restoration of FK506 by chemical complementation with propionic acid. However, trace amount of FK506 product was observed in culture experiments with the addition of acrylic acid to DTcsB. This result further supports that propionic acid rather than acrylic acid is the priming unit directly involved in the biosynthesis of the presumed AM-CoA extender unit.
Biosynthesis and improvement of 36-methyl-FK506 through combined approach of genetic and chemical engineering
To improve the yield of 36-methyl-FK506 through easy and simple combination approach of heterologous FabHlike KSIII encoding gene expression and precursor supplementation, heterologous gene complementation experiment in DTcsB carried out using pSW7 for expression S. glaucescens FAS FabH led to almost 5.8-fold increase in overall 36-methyl-FK506 level in the DTcsB compared with chemical supplementation of the culture with FK506 production (lg/mL) a 8.7 ± 0.8 ND 2.8 ± 0.4 2.5 ± 0.4 3.1 ± 0.2 TA ND not detected, TA trace amount a Cultures were grown for 6 days in R2YE medium. The cell-free broths were collected in the flask by vacuum filtration and then extracted with ethyl acetate for HPLC analysis. An authentic FK506 standard was used to construct a calibration curve of FK506 by HPLC analysis. Data are presented as a mean value ± standard deviation (n = 3) b Final concentration of 10 mM is added 4-methylpentanoic acid. This level was close to that observed for the DtcsB/pMW1 strain (which introduced the isobutyrylmalonyl-CoA pathway in DTcsB, Lechner et al. 2013 ). To further improve the level of 36-methyl-FK506, a precursor for the isobutyryl-CoA pathway, valine was fed into the culture broth of DTcsB/pSW7 in order to elevate the level of isobutyryl-CoA via a multistep oxidation of valine. Consequently, supplementation with 20 mM of valine in DTcsB/pSW7 resulted in an additional 2.5-fold improvement in the FK506 titer as compared with that under the non-supplemented conditions (14.7-fold compared to that observed in DTcsB with 4-methylpentanoic acid). Supplementation of more than 20 mM inhibited the cell growth of DTcsB/pSW7, resulting in a significant decrease in the level of FK506 production. These results indicate that S. glaucescens FAS FabH directly elongates isobutyryl-CoA with malonyl-ACP TcsA , which parallels the initiation step of fatty acid biosynthesis in a type II FAS. Subsequent 4-methyl-2-pentenoyl-ACP TcsA is then reductively carboxylated and dehydrated by CCR homolog TcsC and acyl-ACP dehydrogenase TcsD, respectively, to ultimately provide isobut-2-enylmalonyl-ACP TcsA for enzymatic assimilation into 36-methyl-FK506 (Fig. 6 ).
Discussion
FK506 (also known as tacrolimus or fujimycin, trade names Prograf, Advagraf, Protopic), a 23-membered macrocyclic polyketide, was discovered in the soil bacterium S. tsukubaensis, and its immunosuppressant effect was reported by Kino et al. of Fujisawa Phamaceutical Co. in 1987 (Kino et al. 1987a . The immunosuppressants FK506 and cyclosporine A share a similar mechanism of action, as they both inhibit calcineurin-mediated T-cell activation, thereby decreasing the production of IL-2 (Liu et al. 1991) . FK506 is superior to cyclosporine A in many clinical aspects; therefore, the market share and production volumes of FK506 have been constantly increasing in recent years (Haddad et al. 2006; Webster et al. 2005) . The FK506 biosynthetic gene cluster was sequenced first in Streptomyces sp. strain MA6548 by Motamedi and Shafiee (1998) , and its entire sequence was revealed, including the allylmalonyl-CoA biosynthetic subcluster, in Streptomyces sp. strain KCTC 11604BP (Mo et al. 2011 ) and S. tsukubaensis NRRL 18488 (Goranovič et al. 2010) . We also identified another FK506 biosynthetic gene cluster from Streptomyces sp. KCCM 11116P, which was deposited in the NCBI database under GeneBank accession numbers HQ696504.1. Even though Yoon and colleagues claimed that the genes upstream of AM-CoA biosynthetic genes did not have any obvious role of FK506 biosynthesis in previous studies, we recently reported that the putative extracytoplasmic function sigma (r) factor located upstream of another AM-CoA biosynthetic genes in Streptomyces sp. KCCM 11116P, fujE, is a new member of the FK506 biosynthetic gene cluster (Lee et al. 2014) . In addition, they reported that tcs1, tcs2, tcs3, tcs4, and tcs5 had no effect on FK506 production, but we observed that the production of 36,37-dihydro-FK506 in the tcs1 deletion mutant, which can be detected in high amounts in the DTcsD by HPLC analysis (our unpublished data). In previous studies, exogenously added AM-SNAC was incorporated into the FK520 polyketide chain by the AT domain of the fourth module of FK520 PKS in the S. hygroscopicus ATCC 14891 with relatively high efficiently, and FK506 was successfully generated in the S. hygroscopicus ATCC 14891 (Mo et al. 2011 ). However, they did not generate the FK506 by direct expression of tcsABCD genes in the S. hygroscopicus ATCC 14891. On the other hand, we showed the generation of FK506 by heterologous expression of the tcsABCD genes in S. hygroscopicus ATCC 14891. This observation demonstrated that tcsABCD genes of Streptomyces sp. KCCM 11116P were involved in the formation of the C21 allyl moiety of FK506. In addition, the generation of FK506 by an introduction of AM-CoA biosynthetic genes in FK520 producing strain showed the possibility of biologically installing an allyl moiety onto other polyketide backbones.
Yoon and colleagues reported that propionyl-acylated TcsB, functioning as a priming KS, was proposed to initiate the AM-CoA biosynthetic process by condensing a propyl moiety with malonate loaded on TcsA, an AT-ACP didomain protein, to form an ACP-tethered b-keto-pentanonate to be converted into the resulting trans-2-pentenyl-ACP TcsA by involvement of the KR and DH activities of the FAS of the host (Mo et al. 2011) . Despite the entire reveal the AM-CoA biosynthetic pathway of FK506 biosynthetic gene cluster, the enigma surrounding the function of TcsB has not yet been clearly resolved until this study because Petković and colleagues suggested other possibilities (Goranovič et al. 2010) . A complementation experiment with FabH like-KSIII gene, dpsC, and feeding study with propionic acid were used to confirm that a propionyl-CoA initiates the AM-CoA biosynthesis with malonyl ACP, leading to the restoration of FK506 production in DTcsB. This result clearly shows that TcsB exhibits KSIII activity in catalyzing the condensation of propionyl-CoA and malonyl-ACP TcsA , and propionyl-CoA was the most preferred substrates of TcsB.
Novel analog, 36-methyl-FK506, was produced by chemical supplementation of the culture with 4-methylpentanoic acid in the DTcsB (Mo et al. 2011) . Although new 36-methyl analog exhibits improved neurite outgrowth activity in comparison with the parent natural product FK506, however, the in vivo production levels at 0.06 ± 0.009 mg/L were extremely low. Recently, Moore and colleagues engineered the production of unnatural 36-methyl-FK506 in DTcsB by incorporating the isobutyrylmalonyl-CoA pathway into FK506 biosynthesis in place of its natural C21 allyl side chain, which was resulted in 10-fold higher yields compared 36-methyl-FK506 production in DTcsB when grown R2YE medium supplemented with 4-methylpentanoic acid (Lechner et al. 2013) . However, there is still a big need for the researches to be carried out in order to produce 36-methyl-FK506 biotechnologically and commercially within high efficiency production process. In this study, we reported that the 36-methyl-FK506 yield by plasmid-based expression of a streptomycete fabH and valine supplementation increased to approximately 1 lg/mL, which was close to that observed by DtcsB/pMW1 strain, previously. Generally, the role of FabH-like KSIII initiating these biosynthetic processes and determining the type of product made makes it an attractive target for engineering production of novel natural products. One approach to realize this goal may be protein engineering of the substrate specificity of a PKS FabH. However, we have taken an alternative approach and successfully replaced a FabH-type enzyme from a natural product biosynthetic process with a FAS FabH with different acyl specificity. The streptomycete FAS FabH represents an attractive choice for the replacement enzyme, as an accumulation of evidence has suggested it can utilize a broad array of straight, branched, and cyclic acyl CoA substrates. In doing so, we have accomplished the goal of generating unnatural 36-methyl-FK506. Supplementation of valine might therefore also enhance the level of the 36-methyl-FK506 relative to the non-supplemented fermentation condition. This possibility was investigated by determining the relative amounts of the 36-methyl-FK506 in fermentations of the DTcsB/pSW7 in the presence and absence of valine.
In conclusion, we have identified another AM-CoA biosynthetic genes from new FK506 producing strain, Streptomyces sp. KCCM 11116P, which demonstrated the function of them in formation of the ally unit of FK506 through gene deletion and gene expression in heterologous host. In addition, we elucidate the initial step of AM-CoA pathway by TcsB, an enzyme that has KSIII-like activity with high specificity for propionyl-CoA as the substrate. Supporting evidence was provided by exogenous supplementation with the three-carbon-saturated carboxylic acid, propionate, which was confirmed to be condensed with malonate loaded on TcsA to make the AM-CoA five-carbon extender unit. In particular, using genetic engineering approach, we engineered the production of unique 36-methyl-FK506 by replaced a PKS FabH enzyme from AM-CoA pathway with FAS FabH with branched acylCoA substrates specificity, as well as adding of valine significantly increased the level of 36-methyl-FK506 production, suggested that the exogenously added valine was converted into isobutyryl-CoA by multistep oxidation and that isobutyryl-CoA played a substrate of isobut-2-enylmalonyl-CoA for 36-methyl-FK506 biosynthesis. Although the results showed here are for the wild-type strain, the application of the same approach to higher producing industrial strains may provide the chassis for optimized 36-methyl-FK506 biosynthesis.
